The development of drugs that specifically target DAPK1 signaling pathways could offer new avenues for the treatment of neurodegenerative diseases, providing hope for conditions that currently have limited therapeutic options (65, 83). The gene discussed is DAPK1; the disease is neurodegenerative disease.